HK1253301A1 - 制备胆汁酸衍生物的方法 - Google Patents
制备胆汁酸衍生物的方法 Download PDFInfo
- Publication number
- HK1253301A1 HK1253301A1 HK18112593.6A HK18112593A HK1253301A1 HK 1253301 A1 HK1253301 A1 HK 1253301A1 HK 18112593 A HK18112593 A HK 18112593A HK 1253301 A1 HK1253301 A1 HK 1253301A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261718966P | 2012-10-26 | 2012-10-26 | |
| US61/718,966 | 2012-10-26 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16102102.3A Addition HK1214239B (en) | 2012-10-26 | 2013-10-25 | Process for preparing bile acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1253301A1 true HK1253301A1 (zh) | 2019-06-14 |
Family
ID=50545344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18112593.6A HK1253301A1 (zh) | 2012-10-26 | 2016-02-24 | 制备胆汁酸衍生物的方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US9777038B2 (enExample) |
| EP (1) | EP2912013B1 (enExample) |
| JP (1) | JP6272888B2 (enExample) |
| KR (1) | KR102068381B1 (enExample) |
| CN (2) | CN105102425B (enExample) |
| AU (1) | AU2013334122B2 (enExample) |
| BR (1) | BR112015009395A2 (enExample) |
| CA (1) | CA2889592A1 (enExample) |
| CY (1) | CY1119731T1 (enExample) |
| DK (1) | DK2912013T3 (enExample) |
| ES (1) | ES2655034T3 (enExample) |
| HK (1) | HK1253301A1 (enExample) |
| HU (1) | HUE036887T2 (enExample) |
| IL (1) | IL238454B (enExample) |
| MX (1) | MX361653B (enExample) |
| NO (1) | NO2968302T3 (enExample) |
| NZ (2) | NZ745013A (enExample) |
| PL (1) | PL2912013T3 (enExample) |
| PT (1) | PT2912013T (enExample) |
| SG (1) | SG11201503247UA (enExample) |
| SM (1) | SMT201700602T1 (enExample) |
| WO (1) | WO2014066819A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2912013B1 (en) | 2012-10-26 | 2017-10-11 | Intercept Pharmaceuticals, Inc. | Process for preparing bile acid derivatives |
| FI3626725T3 (fi) * | 2014-05-29 | 2023-03-16 | Bar Pharmaceuticals S R L | Kolaanijohdannaisia käytettäväksi FXR:n ja TGR5:n/GPBAR1:n välittämien sairauksien hoidossa ja/tai ennaltaehkäisyssä |
| CN107108687B (zh) | 2014-11-19 | 2019-10-29 | Nzp英国有限公司 | 作为制备类固醇FXR调节剂的中间体的5β-6-烷基-7-羟基-3-酮类固醇 |
| CA2968310A1 (en) | 2014-11-19 | 2016-05-26 | NZP UK Limited | 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators |
| TWI690536B (zh) | 2014-11-19 | 2020-04-11 | 英商Ｎｚｐ英國有限公司 | 化合物（一） |
| KR102546748B1 (ko) | 2014-11-19 | 2023-06-22 | 엔제트피 유케이 리미티드 | 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-3,7-다이온 스테로이드 |
| CN104672290B (zh) * | 2015-01-05 | 2017-06-06 | 北京普禄德医药科技有限公司 | 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途 |
| US11311557B2 (en) | 2015-02-06 | 2022-04-26 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions for combination therapy |
| EP3353189A4 (en) | 2015-09-24 | 2019-06-19 | Intercept Pharmaceuticals, Inc. | METHOD AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF GALLENIC ACID DERIVATIVES |
| AU2016350690C1 (en) * | 2015-11-06 | 2020-04-23 | Intercept Pharmaceuticals, Inc. | Methods for the preparation of obeticholic acid and derivatives thereof |
| US20200262865A1 (en) * | 2016-02-15 | 2020-08-20 | Alexander Khoruts | Compositions and methods for treating clostridium associated diseases |
| US10369160B2 (en) | 2016-04-13 | 2019-08-06 | Intercept Pharmaceuticals, Inc. | Methods of treating cancer |
| TW201738254A (zh) * | 2016-04-19 | 2017-11-01 | 英特賽普醫藥品公司 | 奧貝膽酸及其衍生物之製備方法 |
| GB201608777D0 (en) | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Compounds |
| GB201608776D0 (en) | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Methods and compounds |
| CA3038534A1 (en) * | 2016-09-30 | 2018-04-05 | Intercept Pharmaceuticals, Inc. | Crystalline forms of a bile acid derivative |
| MX2020000873A (es) | 2017-07-24 | 2020-07-22 | Intercept Pharmaceuticals Inc | Derivados de ácidos biliares marcados isotópicamente. |
| CN110869381B (zh) * | 2017-07-26 | 2021-11-19 | 正大天晴药业集团股份有限公司 | 甾体类衍生物fxr激动剂的制备方法 |
| GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
| CA3142358A1 (en) | 2019-05-30 | 2020-12-03 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease |
| WO2021071837A1 (en) | 2019-10-07 | 2021-04-15 | Kallyope, Inc. | Gpr119 agonists |
| TW202140440A (zh) | 2020-02-28 | 2021-11-01 | 美商克力歐普股份有限公司 | Gpr40激動劑 |
| UY39222A (es) | 2020-05-19 | 2021-11-30 | Kallyope Inc | Activadores de la ampk |
| AU2021297323A1 (en) | 2020-06-26 | 2023-02-16 | Kallyope, Inc. | AMPK activators |
| JP7583398B2 (ja) | 2020-09-18 | 2024-11-14 | ソウル大学校産学協力団 | タウロデオキシコール酸ナトリウムの大量生産方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5216015A (en) * | 1991-02-05 | 1993-06-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having hypocholesterolemic properties |
| ES2248581T3 (es) | 2001-03-12 | 2006-03-16 | Intercept Pharmaceuticals, Inc. | Esteroides como agonistas de fxr. |
| EP1568706A1 (en) | 2004-02-26 | 2005-08-31 | Intercept Pharmaceuticals, Inc. | Novel steroid agonist for FXR |
| CA2656320C (en) | 2006-06-27 | 2015-04-28 | Intercept Pharmaceuticals, Inc. | Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| WO2010036427A1 (en) * | 2008-06-17 | 2010-04-01 | Brigham Young University | Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
| AU2009276507B2 (en) * | 2008-07-30 | 2015-11-19 | Intercept Pharmaceuticals, Inc. | TGR5 modulators and methods of use thereof |
| CN106380502A (zh) * | 2008-11-19 | 2017-02-08 | 英特塞普特医药品公司 | G蛋白偶联受体5(tgr5)调节剂及其使用方法 |
| EP2912013B1 (en) | 2012-10-26 | 2017-10-11 | Intercept Pharmaceuticals, Inc. | Process for preparing bile acid derivatives |
-
2013
- 2013-10-25 EP EP13849263.2A patent/EP2912013B1/en not_active Not-in-force
- 2013-10-25 NZ NZ745013A patent/NZ745013A/en not_active IP Right Cessation
- 2013-10-25 BR BR112015009395A patent/BR112015009395A2/pt not_active Application Discontinuation
- 2013-10-25 WO PCT/US2013/066917 patent/WO2014066819A1/en not_active Ceased
- 2013-10-25 SG SG11201503247UA patent/SG11201503247UA/en unknown
- 2013-10-25 ES ES13849263.2T patent/ES2655034T3/es active Active
- 2013-10-25 KR KR1020157012805A patent/KR102068381B1/ko not_active Expired - Fee Related
- 2013-10-25 HU HUE13849263A patent/HUE036887T2/hu unknown
- 2013-10-25 CA CA2889592A patent/CA2889592A1/en not_active Abandoned
- 2013-10-25 SM SM20170602T patent/SMT201700602T1/it unknown
- 2013-10-25 CN CN201380068062.XA patent/CN105102425B/zh not_active Expired - Fee Related
- 2013-10-25 PL PL13849263T patent/PL2912013T3/pl unknown
- 2013-10-25 US US14/438,323 patent/US9777038B2/en active Active
- 2013-10-25 NZ NZ707389A patent/NZ707389A/en not_active IP Right Cessation
- 2013-10-25 DK DK13849263.2T patent/DK2912013T3/en active
- 2013-10-25 MX MX2015005286A patent/MX361653B/es active IP Right Grant
- 2013-10-25 AU AU2013334122A patent/AU2013334122B2/en not_active Ceased
- 2013-10-25 JP JP2015539862A patent/JP6272888B2/ja not_active Expired - Fee Related
- 2013-10-25 PT PT138492632T patent/PT2912013T/pt unknown
- 2013-10-25 CN CN201810282054.XA patent/CN108250264A/zh active Pending
-
2014
- 2014-03-14 NO NO14725812A patent/NO2968302T3/no unknown
-
2015
- 2015-04-26 IL IL238454A patent/IL238454B/en active IP Right Grant
-
2016
- 2016-02-24 HK HK18112593.6A patent/HK1253301A1/zh unknown
-
2017
- 2017-08-21 US US15/681,609 patent/US10202414B2/en not_active Expired - Fee Related
-
2018
- 2018-01-03 CY CY20181100003T patent/CY1119731T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1253301A1 (zh) | 制备胆汁酸衍生物的方法 | |
| JP5202635B2 (ja) | インテグラーゼ阻害剤の調製のためのプロセスおよび中間体 | |
| KR100555970B1 (ko) | 2-아미노-1,3-프로판디올유도체의 제조방법 | |
| ES2717226T3 (es) | Método de producción de beraprost | |
| EP1806338B1 (en) | Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof | |
| CN102630226A (zh) | 恩替卡韦的合成方法及其中间体化合物 | |
| KR20090066910A (ko) | Ｌ-3-ｏ-치환-아스코르브산의 개선된 제조방법 | |
| WO2016004805A1 (zh) | 一种艾日布林中间体的制备方法 | |
| TWI623521B (zh) | 一種製備利馬前列素的中間體、其製備方法以及藉由其製備利馬前列素的方法 | |
| HK1214239B (en) | Process for preparing bile acid derivatives | |
| US6753435B1 (en) | Intermediates for vitamin D and processes for the preparation thereof | |
| US20070129558A1 (en) | Monohalogenovinyl vitamin d derivative compounds | |
| JP2752489B2 (ja) | 新規な大環状化合物及びその製造方法 | |
| JP2016501258A (ja) | １０−デアセチルバッカチンｉｉｉからカバジタキセルを高収率で製造する新規方法及びそのための新規中間体 | |
| RO133248A2 (ro) | Amine biciclo[2.2.1]heptanice protejate la grupa hidroxil | |
| KR19980065189A (ko) | 무스콘의 신규합성중간체 및 그의 제조방법 | |
| JP2008255049A (ja) | 有機アンチモン化合物、その製造方法及びこれを用いたセンサー | |
| JP2019131510A (ja) | ルビプロストンの製造方法 | |
| PL213059B1 (pl) | Chiralny karboksyester dimetylocyklopropanui sposób jego wytwarzania | |
| TW201920106A (zh) | 製備１－［６－鹵－３－吡啶基］酮之方法 | |
| CN102690254A (zh) | 辛伐他汀铵盐中间体及其制备方法 | |
| KR20060094553A (ko) | 2＇,2＇-디플루오로뉴글레오시드 중간체의 제조방법 | |
| PL197215B1 (pl) | Nowy chiralny bromospirolakton karanu i sposób jego wytwarzania | |
| JPH01100195A (ja) | １α，２４―ジヒドロキシコレステロール類の製造法 | |
| KR19980065188A (ko) | 무스콘의 신규합성중간체 및 그의 제조방법 |